Home › Leucemia linfoblastica acuta › Utah › Salt Lake City
Studi clinici su Leucemia linfoblastica acuta a Salt Lake City, UT
10 studi su Leucemia linfoblastica acuta cercano partecipanti presso sedi a Salt Lake City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
In reclutamentoFase 1
- Primary Children's Hospital, Salt Lake City
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
In reclutamento
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
In reclutamentoFase 1
- Huntsman Cancer Institute, Salt Lake City
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
In reclutamentoFase 1/2
- Primary Children's Hospital, Salt Lake City
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
In reclutamentoFase 2
- Primary Children's Hospital, Salt Lake City
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- University of Utah, Salt Lake City
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
In reclutamentoFase 1/2
- University of Utah Huntsman Cancer Institute, Salt Lake City
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
In reclutamentoFase 1
- University of Utah, Salt Lake City
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
In reclutamentoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
In reclutamentoFase 1
- Primary Children's Hospital, Salt Lake City
Studi su Leucemia linfoblastica acuta in altre città
- Houston, TX28 studi
- New York City, NY23 studi
- Seattle, WA21 studi
- Baldwin Park, CA21 studi
- Chicago, IL20 studi
- Atlanta, GA19 studi
- Memphis, TN16 studi
- Washington, DC16 studi
- Philadelphia, PA16 studi
- Boston, MA15 studi
- Los Angeles, CA14 studi
- Mountain View, CA13 studi
Altri studi a Salt Lake City
- Cancro del polmone non a piccole cellule31 studi
- Cancro (tutti i tipi)27 studi
- Cancro al seno27 studi
- Cancro colorettale22 studi
- Cancro ai polmoni21 studi
- Melanoma21 studi
- Mieloma multiplo21 studi
- Cancro metastatico20 studi
- Cancro ovarico19 studi
- Obesità18 studi
- Leucemia mieloide acuta17 studi
- Insufficienza cardiaca17 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.